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Abstract
Background:  Diagnosis of Mycoplasma pneumoniae (MP) infection is traditionally based on
serology, which may require more than two weeks for diagnostic antibodies to develop. PCR-based
methods offer earlier diagnosis. During a community outbreak of MP infection, we compared semi-
nested and real-time PCR of oropharyngeal swabs with serology for diagnosis of MP infection at
different time points after disease onset. PCR-positive individuals were followed longitudinally to
assess the persistence of MP DNA in throat secretions. We also studied carriage of MP among
household contacts and school children.
Results: MP infection was diagnosed in 48 of 164 patients with respiratory tract infection. Forty-
five (29%) had detectable MP DNA in oropharynx. A significant increase in MP IgG IgG titre or MP
IgM antibodies was detected in 44/154 (27%) subjects. Two MP PCR-positive patients lacked
antibody responses. Sera were missing from another two patients. The agreement between
serology and PCR was good, κ = 0.90.
During the first three weeks after disease onset the performance of PCR was excellent and all
patients but one were detected. In contrast, only 21% of the patients with confirmed MP infection
were positive by serum 1 during the first symptomatic week (56% during the second and 100%
during the third week). Only 1/237 (0.4%) school children was positive by PCR. This child had
respiratory symptoms. Eighteen of 22 (75%) symptomatic household contacts were MP PCR
positive.
Persistence of MP DNA in the throat was common. Median time for carriage of MP DNA was 7
weeks after disease onset (range 2 days – 7 months). Adequate antibiotic treatment did not shorten
the period of persistence. Bacterial load, measured by quantitative real-time PCR declined
gradually, and all followed patients eventually became PCR-negative.
Conclusion: PCR is superior to serology for diagnosis of MP infection during the early phases of
infection. Persistent, sometimes long-term, carriage of MP DNA in the throat is common following
acute infection, and is not affected by antibiotic therapy. Asymptomatic carriage of MP even during
an outbreak is uncommon.
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Background
Mycoplasma pneumoniae (MP) is a small bacterium without
a cell wall. It is recognized as a common cause of commu-
nity-acquired pneumonia and upper respiratory tract
infections, especially in children and adolescents,
although all age groups may be affected. MP infections
tend to occur in epidemics with a predilection for cluster-
ing in families and groups with close contacts such as mil-
itary conscripts [1,2]. Following an incubation period of
two to three weeks, the infection is characterised by respi-
ratory symptoms with cough, fever and malaise. MP infec-
tion is usually self-limited, but treatment with antibiotics
such as erythromycin, tetracycline or quinolones is often
prescribed.
Traditionally, diagnosis of MP infection has been based
on serology, using either a rise of IgG titre in paired sera,
or the detection of MP IgM in acute phase serum. How-
ever, antibodies may not appear until two weeks after the
onset of symptoms, and may thus provide a diagnosis
only retrospectively in many cases [3]. Apart from low
sensitivity in acute disease, serological tests may also have
specificity problems [4]. Direct methods for diagnosing
MP infection have therefore been considered. Culture of
MP is difficult to perform, takes a long time and is not
suitable for clinical practice. Instead, detection by PCR
from respiratory secretions has been suggested as a more
sensitive and practical diagnostic tool [5-8]. PCR methods
targeting the adherence protein P1 or the 16S RNA gene,
as well as other genes have been described [7,9-15]. Most
comparative studies of serology and PCR have included
small numbers of MP-positive cases [7,10,16-18] and
only rarely has it been possible to evaluate the perform-
ance of the tests at different intervals after onset of illness
[4]. Furthermore, asymptomatic carriage could compli-
cate the assessment of a positive PCR finding. Rates of MP
carriage in healthy people have been reported to be
between 0–13.5% [7,8,19,20].
MP infection can sometimes cause persistent respiratory
symptoms, as well as a range of late-stage extra-pulmo-
nary complications. The aetiology of these manifestations
is not clear; although immune-mediated pathogenesis
may be responsible, long-term MP infection could also be
involved.
This study compares the performance of DNA detection
by PCR and serology at different time points after onset of
symptoms in MP infection. To assess the prevalence of
asymptomatic carriage, school children were examined
during a community outbreak of MP infection. A longitu-
dinal follow-up was also performed in PCR-positive
patients to determine the rate of bacterial clearance. In
addition, the prevalence of carriage of MP was studied
among household contacts to some of the patients.
Methods
Material
The study was performed in the city of Malmö and adja-
cent suburban areas (pop. approx. 360 000) in the south
of Sweden between September 20, 2005 and March 15,
2006. During this period an increased number of MP
infections were noted in the diagnostic serological labora-
tory at the Department of Clinical Microbiology. Three
groups of subjects were included in the study: patients
with symptoms compatible with MP infection, household
contacts of MP-infected patients, and school children
healthy enough to be in school.
Patients with acute respiratory symptoms including cough
were eligible for inclusion. No exclusion criteria were
applied. Study participants were recruited from four pri-
mary health care centres in Malmö and from the Depart-
ment of Infectious Diseases at Malmö University
Hospital. One hundred-sixty-four patients were included
(62% women, 38% men; median age 41 years [range 2 –
82]).
Children aged 10–16 years; were recruited from a primary
school in Malmö. Two hundred thirty-seven children were
included, and had a throat swab for PCR taken on one sin-
gle day. Additionally 22 out of 25 household contacts to
ten positive index cases in ten different families were
investigated by PCR.
Study procedure
Samples for PCR testing were obtained from oropharynx
at the posterior pharyngeal wall by a cotton-tipped swab
and transferred to a tube containing either a transport
medium consisting of 1 mL of phosphate buffered saline
supplemented with bensylpenicillin 150 μg/mL, gen-
tamicin 10 μg/mL and amphotericin 2 μg/mL, or a com-
mercial transport medium (Copan Italia SPA, Brescia,
Italy).
Serum samples were collected on the first visit and at least
2–4 weeks later.
Patients and household contacts were asked to provide
both throat samples and a blood sample for serology,
whereas only throat samples were obtained from school
children. Household contacts and school children
answered questionnaires concerning disease symptoms at
the time of sampling and during the preceding weeks.
Subjects who were positive by PCR were invited to follow-
up PCR testing every two weeks until two consecutive
samples were negative. Three to six months after having
submitted the last PCR-negative throat sample, these indi-
viduals were asked to return for another throat PCR sam-
ple in order to evaluate potential bacterial recurrence.BMC Microbiology 2008, 8:93 http://www.biomedcentral.com/1471-2180/8/93
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Methods
PCR
Samples for PCR analysis were placed in tubes containing
phosphate buffered saline (PBS), and DNA was extracted
using a MagNa Pure LC instrument and a MagNa Pure LC
DNA I isolation kit (Roche Diagnostics GmbH, Man-
nheim, Germany). Nucleic acid from a 200-μL aliquot of
each sample was finally obtained in 75 μL elution buffer,
and a semi-nested PCR was performed using primers
described elsewhere [21]. Amplified DNA was subjected
to gel electrophoresis after a characteristic amplification
product detected by ethidium bromide staining. The fol-
lowing primers were used:
MP11 5'-TGC CAT CAA CCC GCG CTT AAC
MP12 5'-CCT TTG CAA CTG CTC ATA GTA
MP-I 5'-CAA ACC GGG CAG ATC ACC TTT
Semi-nested PCR was carried out using MP11/MP12 fol-
lowed by MP12/MP-I, which yields a 201-bp-long frag-
ment. A PCR mixture (total volume 50 μL) was prepared
that included 10 μL of the sample containing each nucle-
otide at a concentration of 200 nM, each primer at 500
nM, 2 μM MgCl2, and 1.5 u Taq-polymerase (Go-Taq,
Promega, Madison, WI, USA).
A quantitative real-time PCR (qPCR) method was used to
measure the load of MP at different time points in patients
with positive reactions in semi-nested PCR. Primers were
MP 435 5'-GGCAGTCAACAAACCACGTATG and MP 479
5'-GGTGGTTGATGCGGTCAAA with the probe MP 509
FAM-5'-CCCACCCGAACCGAAGCGG-TAMRA. The
amplification fragment was cloned into a plasmid vector,
which was used as a standard for quantification. Real time
PCR was performed using a GeneAmp 5700 Sequence
Detector (Applied Biosystems, Foster City, CA, USA). A
PCR mixture (25 μL) was prepared that included 5 μL of
the sample containing each primer at 400 nM, 250 nM
probe and each nucleotide at 200 nM, and 1.5 u GoldTaq
(Applied Biosystems/Roche, Branchburg, NJ, USA)
Serology
IgG antibodies were measured using the Serion Elisa Myc-
oplasma pneumoniae IgG kit (Institut Virion/serion
GmbH, Würzburg, Germany) with the test cut-off
0,5×mean optical density (OD) value of the kit control
serum, as indicated in the insert. A positive IgG reaction
was defined as >30 AU/mL. A significant rise in IgG titre
was considered to be a doubling of the OD value above
the cut-off, or a sero-conversion in which the primary
serum was antibody negative and the second serum had
an OD at least twice the cut-off corresponding to a three-
fold rise in AU/mL titre. IgM antibodies were measured
using the SeroMP™ IgM kit (Savyon® Diagnostics Ltd. Ash-
dod, Israel). A calibration line obtained by the standard
sera in the kit was used to determine the IgM titre in BU/
mL. A positive IgM antibody reaction was defined as >20
BU/mL according to the instruction of the manufacturer.
Gold standard and discrepant analysis
Diagnosis of MP infection was based on serology or PCR
findings. A significant rise in MP IgG or seroconversion in
paired sera or the presence of IgM antibodies to MP were
used as sufficient criteria of current MP infection. MP
infection was also considered to be present by DNA detec-
tion when two independent PCR methods were positive.
In cases with positive PCR results in the absence of MP
antibodies, sequencing was done to confirm the presence
of MP infection. Two consecutive samples negative by
PCR were considered a microbiological resolution of MP
infection.
Statistical analysis
Agreement of the results was calculated using the kappa
index. Differences between mean values and between fre-
quencies were tested by the Mann-Whitney U test and the
chi-square test, respectively. Persistence of M. pneumoniae
DNA was studied by survival analysis according to Kap-
lan-Meier. The Statistica package was used (StatSoft Inc.,
Tulsa OK, USA).
Ethical considerations
The ethics committee of the University of Lund approved
the study, and written informed consent was obtained
from all patients or from their caretakers.
Results
Comparison of PCR and serology
Among 164 patients included in the study, 45 (27%) were
positive by PCR in throat swabs on at least one occasion
(Table 1). Sera were available for 154 patients, of whom
44 (29%) had a significant antibody response. For 96
patients with paired sera and throat swabs, the agreement
between serology and PCR was κ = 0.90. Three PCR-posi-
tive cases (11, 33 and 79 years old) had unexpectedly late
serological responses. Their first serum samples were
obtained during the fourth week of illness when they had
low IgG titres and undetectable IgM. MP infection was
serologically confirmed by IgG titre rise in convalescent
phase samples obtained on days 41, 58, and 80, respec-
tively.
The time interval between onset of illness and first sample
was essential for the sensitivity of serology. During the
early stages of illness PCR was clearly superior to serology
in identifying MP. Only 21% of the MP cases had a diag-
nostic antibody reaction in their acute phase serum
obtained during the first week of illness, whereas all testedBMC Microbiology 2008, 8:93 http://www.biomedcentral.com/1471-2180/8/93
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patients with confirmed MP infection were positive at that
time. During the second week of illness, 56% of the MP
cases were detected by serology and 96% by PCR (Table
2).
Patients who presented during the third week of illness
were all positive by PCR and serology. The sensitivity of
PCR declined in the small number of patients who had
their first test later than three weeks after onset of symp-
toms.
Quantitative PCR could be carried out in 44 of the 45
patients who were positive by semi-nested PCR. One sam-
ple contained insufficient material for analysis but the
infection was confirmed by IgG titer rise. qPCR confirmed
MP infection in 42/44 cases while two cases tested nega-
tive by this method. These two cases were further analysed
by DNA sequencing and found to belong to genotype 2 of
MP thus confirming MP infection.
Discrepant findings of PCR and serology
Two patients had repeated samples positive by PCR but
did not develop antibody responses. Both had symptoms
suggestive of MP infection. One of them was pregnant in
the third trimester. Serum samples were collected from
this patient (age 29 years) on days 30, 46 and 60 after
onset of symptoms (PCR positive on days 30 and 46) and
from the other patient (age 53 years) on days 1 and 36
(PCR positive on days 1 and 7). The nested PCR results
were confirmed by qPCR and also by sequencing the MP
genome. Three other patients (79, 34 and 69 years old)
had serological responses indicating MP infection but
were negative by PCR. Sera and samples for PCR were
taken on days 25/58, 27/41 and 11 respectively. The first
two patients had a significant titre rise of IgG antibodies.
The third patient had a positive IgM reaction for MP on
day 11 but lacked IgG antibodies at that time.
Bacterial load by quantitative PCR (qPCR)
The qPCR was compared to the established semi-nested
PCR in 142 clinical samples obtained for routine testing
of MP infection. The semi-nested PCR detected 24 positive
cases (17%) and the qPCR 23 of the 24 positive cases. The
sensitivity and specificity for the qPCR were 96% and
100% respectively.
The patients of the present study were also followed lon-
gitudinally by qPCR. The bacterial load in consecutive
samples gradually declined in relation to the time interval
from onset of illness to sampling. Figure 1 shows the geo-
metric mean copy numbers of organism DNA observed
during each week and a calculated regression line.
Forty-three of the individuals followed longitudinally
were prescribed antibiotic treatment active against MP on
basis of clinical symptoms by the attending physician. The
treatment of choice was erythromycin, roxitromycin, tet-
racycline or levofloxacin. Ten patients did not receive any
antibiotic treatment. The median period of persistence of
MP among the 43 cases treated with antibiotics was 52
days (range 2–229) compared to 45 days (range 1–116)
among the 10 untreated cases. No difference in persist-
Table 1: MP infection diagnosed by PCR and serology in 164 patients with respiratory tract infection.
Pcr reaction Patients with paired sera Patients with single sera Total serum results Patients without sera Total
Ser+* Ser-** Ser+*** Ser-** Ser+* Ser-**
PCR+ 25 2 16 0 41 2 2 45
PCR- 2 67 1 41 3 108 8 119
Total 27 69 17 41 44 110 10 164
* = IgM+ or IgG seroconversion
** = IgM- and IgG-
*** = IgM+
Table 2: Performance of serology and PCR at first visit in patients with MP infection in relation to duration of illness.
Days after onset of illness MP cases detected by PCR (%) MP cases detected by serology. Results of the first serum (%)
Negative Positive Negative Positive
1 – 7 0 17 (100) 10 3 (23)
8 – 14 1 23 (96) 8 10 (56)
15 – 21 0 8 (100) 0 6 (100)
22 – 28 2 5 (71) 5 1 (17)
> 28 0 8 (100) 2 9 (82)
Total 3 61 (95) 25 29 (54)BMC Microbiology 2008, 8:93 http://www.biomedcentral.com/1471-2180/8/93
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ence was demonstrated between these groups using the
Mann-Whitney U test, p = 0.16.
Long term persistent infection
Results from follow-up samples by PCR and qPCR were
complete in 46 individuals (patients and family contacts)
and incomplete in an additional 14 cases. A survival curve
according to Kaplan-Meier for these 60 PCR positive cases
is shown in Fig. 2. Long-term persistence of MP was com-
mon after the acute phase of the illness. Half of the cases
were positive after 54 days.
Median follow-up time of the individuals was 138 days,
range 11–337 days. Late samples were obtained from 33
patients three to six months after microbiological resolu-
tion of their infections, and 32 of those were PCR nega-
tive. One case had become positive again after two
negative samples three months earlier, but eventually
became negative after an additional three months.
School children
Among 237 school children, 236 were negative by MP
PCR in throat swabs. One 14-year-old boy was PCR-posi-
tive, and subsequently tested positive in repeated samples
obtained over the following three months. This boy was
found to have symptoms of respiratory tract infection
compatible with MP infection, and his condition
improved by treatment with erythromycin. All school
children were also tested for Chlamydophila pneumoniae by
PCR but no such infection was found.
Family contacts
In 18 of the 22 tested family members in ten families with
an index case MP DNA was detected by semi-nested PCR
and quantitative PCR. All PCR-positive family members
had ongoing or recent respiratory tract symptoms at the
time of testing. One child was healthy and negative on ini-
tial testing, but later developed symptoms and became
PCR positive.
Discussion
Although rarely fatal, Mycoplasma pneumoniae is an impor-
tant cause of acute respiratory tract infection, especially as
a potential aetiology of the clinical entity termed "atypical
pneumonia". Its occurrence among patients with commu-
nity-acquired pneumonia has even led to recommenda-
tions to include antibiotics active against this organism in
the first-line therapy for such patients in some national
guidelines for management of pneumonia [22]. In order
to improve identification of patients in need of such treat-
ment, and to avoid unnecessary antibiotic therapy, early
diagnosis of MP infection is essential.
During the early phase of MP disease, serological methods
have low sensitivity and can often only provide a retro-
spective diagnosis. In contrast, PCR tests on respiratory
secretions may provide an early diagnosis for MP infec-
tion and could be a useful diagnostic alternative. In this
study, we compared PCR from throat swabs and serology
in symptomatic patients tested during a community out-
break of MP, and found that PCR on throat swabs
detected 93% of patients who later developed an antibody
response to MP. In addition, two patients had positive
PCR results, but did not develop detectable MP antibodies
during follow-up. The superior sensitivity of PCR was
noted in patients tested during the first two weeks after
onset of illness. Less than half of patients had detectable
MP antibodies during this period.
These findings are in agreement with other studies
[4,7,10,16-18] and suggest that PCR testing should be
Decline of carriage rate of M. pneumonaiae over time  reflected in a Kaplan-Meier curve based on 60 PCR positive  patients Figure 2
Decline of carriage rate of M. pneumonaiae over time 
reflected in a Kaplan-Meier curve based on 60 PCR 
positive patients.
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considered as the method of choice for diagnosis of MP
infection during the early stages of illness.
The drawbacks of PCR are the risks for contamination dur-
ing processing of the samples or the risk for false negative
results due to inhibitory factors in the samples. We puri-
fied DNA by the MagnaPure kit, which diminishes the
influence of inhibitory factors. The PCR results were
reproduced by two independent methods and in addition
most patients were positive in two or more samples. Pos-
itive PCR results were also corroborated by serological
results in all but two cases. These two cases had repeated
samples positive by both semi nested PCR and qPCR and
seem to represent true MP infections. False positive sero-
logical results may also occur, in particular regarding IgM
[4]. We had three cases with diagnostic antibody
responses but with negative PCR results. In one case the
diagnosis was based solely on an elevated IgM titre but the
other two cases had significant IgG titre rises in paired
sera. The samples for PCR were obtained late for the last
two cases, which may explain the discrepant results. The
serum sample from the IgM positive cases was obtained
during the second week of illness together with a PCR neg-
ative throat swab. Whether this represented a false nega-
tive PCR or a false positive IgM reaction could not be
resolved.
The sensitivity of PCR testing depends on the type of sam-
ple tested. We used throat secretions obtained in the
oropharynx, since such samples are easier to obtain than
nasopharyngeal swabs or sputum samples. Besides, spu-
tum production is often minimal in patients with MP
infection. Previous reports have found that sputum sam-
ples give the highest rate of positive findings, followed by
nasopharyngeal swabs as the second best, with throat
swabs appearing to be less efficient. Räty et al. reported a
sensitivity of sputum samples of 69%, nasopharyngeal
swabs of 50% and throat swabs 37.5% [23]. Nadal et al.
observed a sensitivity of 90% for nasopharyngeal swabs as
compared to 79% for throat swabs [10]. Throat washings
may seem to be better than swabs [24]. However, less dis-
tinctive differences have also been reported [25-27].
We used throat swabs in our study, and found that the
clinical sensitivity was high, since only 3 of 44 samples
from patients with positive MP serology were PCR nega-
tive. It is possible that the yield was improved by the fact
that our samples were obtained by swabbing the posterior
wall of the oropharynx and not the tonsil area.
The interpretation of a positive MP PCR result would be
difficult if asymptomatic carriers were common. The high-
est incidence of MP infection is considered to occur in
children 5–15 years of age [28]. To assess the prevalence
of asymptomatic carriers in this age group, we performed
PCR testing among children in a school at one single day
during the outbreak. Only one of the children (0.4%) was
found to be positive, and this child was in fact sympto-
matic. Other studies have shown carrier rates of
0.1–13.5% detected by culture or PCR in healthy subjects
during low and high prevalence periods [20,28]. Moreo-
ver, no positive cases were found by Dorigo-Zetsma and
colleagues [7] among 74 controls or by Kai et al. [8]
among 33 healthy volunteers. Our data corroborate previ-
ous reports that the frequency of asymptomatic carriers is
low in the general population, even during an outbreak of
MP infection.
In contrast, among household contacts to patients with
confirmed MP infection, we found high rates of MP in
throat secretions. All of these subjects had respiratory
symptoms. Similarly, Dorigo-Zetsma and co-workers
found household members at increased risk of MP infec-
tion transmitted by the index case, although not all of
these were symptomatic [29].
During longitudinal follow-up, we observed that the
majority of PCR-positive patients had persistent infection,
even though many of them had received adequate antibi-
otic treatment. More than half of the patients had detect-
able MP DNA in throat secretions for seven weeks after
onset of illness, and several patients continued to be PCR
positive for several months. In some cases, prolonged
infection was accompanied by mild respiratory symp-
toms; however, the significance of MP persistence with
respect to such symptoms is difficult to evaluate.
The load of MP DNA gradually declined over time, and
eventually all tested subjects became PCR negative. This
pattern argues against a transition from active clinical
infection into a state of chronic colonization. The persist-
ence of DNA from dead bacteria after antibiotic treatment
might occur, but can hardly explain the presence of MP in
pharyngeal secretions several months after acute infec-
tion. Viable MP bacteria have been isolated by culture for
six weeks or longer after resolution of clinical disease [28].
Most of our patients, particularly those who were hospi-
talized, received antibiotic treatment.
However, in accordance with other investigators [6,19] we
could not demonstrate that the rate of clearance was
shortened by such treatment. MP adheres to epithelial
cells, which seems to be necessary for the pathogenicity of
the bacteria. Furthermore, some Mycoplasma species such
as MP and M. genitalium have even been found within
host cells. This might suggest that antibiotics with potent
intracellular activity are required for resolution of MP
infection. M. genitalium can be effectively eradicated by
azithromycin, but it is not yet known whether that is alsoBMC Microbiology 2008, 8:93 http://www.biomedcentral.com/1471-2180/8/93
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the case for MP. Although only an anecdotal observation,
in three symptomatic long-term carriers included in our
study, MP DNA became undetectable and mild persistent
respiratory symptoms disappeared following azithromy-
cin therapy. In addition, other researchers have reported
that this drug can reduce transmission of MP [30].
There are several limitations of the present study. The
patients were mainly recruited at a hospital department
and only few MP cases were detected among patients
attending general practitioners. Therefore patients with
more severe symptoms may have been overrepresented.
The patients are also more likely to have received antibi-
otic treatment due to the clinical manifestations. The
study group mainly includes adults as children are man-
aged at the department of paediatrics.
Our study confirms and reiterates the usefulness of PCR
for early diagnosis of MP infection. False negative serolog-
ical results are common during the first two weeks of ill-
ness, but PCR testing of throat swabs from the posterior
pharyngeal wall, the oropharynx seem to detect MP at this
stage of infection. MP infection is rarely found in healthy
people in the community during outbreaks, with the
exception of household contacts to confirmed MP cases.
MP DNA usually remains detectable by PCR in throat
swabs for several weeks after onset of symptoms, and can
persist for months, with a gradual decline in bacterial load
over time.
Conclusion
The use of PCR, using either semi-nested or quantitative
real-time methods, was superior to serology for diagnos-
ing acute Mycoplasma Pneumoniae infections during the
first two weeks after onset of illness. During this period, a
serological response could be detected only in 23–56% of
the cases, whereas PCR detected 96–100% of the cases.
During later stages of illness, the rate of positive PCR reac-
tions was lower. A gradual decline in the rate of PCR pos-
itive patients was observed over time but half of the
patients were still positive 7 weeks after disease onset. All
patients eventually became PCR negative but one patient
remained positive for seven months. In addition, the bac-
terial load decreased over time, suggesting gradual clear-
ance rather than a transition from illness to a state of
persistent carriage. Only 1/237 school children had a pos-
itive MP PCR, and this individual had symptoms of respi-
ratory tract infection at the time of testing. Thus, MP
carriage among asymptomatic persons seems to be rare
even during an outbreak of MP infection. A positive PCR
test for MP should therefore be interpreted as a clinically
significant MP infection.
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